Avalon GloboCare Corp. (NASDAQ:ALBT) Short Interest Up 358.6% in February

Avalon GloboCare Corp. (NASDAQ:ALBT) saw a significant increase in short interest in February. As of February 28th, there was short interest totalling 45,400 shares, an increase of 358.6% from the February 13th total of 9,900 shares. Currently, 10.7% of the company’s stock are short sold. Based on an average daily trading volume, of 858,400 shares, the short-interest ratio is presently 0.1 days.

Avalon GloboCare Price Performance

Shares of NASDAQ:ALBT opened at $4.88 on Thursday. The stock has a market capitalization of $5.34 million, a P/E ratio of -0.24 and a beta of -0.11. The business has a 50-day moving average of $4.66 and a two-hundred day moving average of $3.83. Avalon GloboCare has a fifty-two week low of $2.11 and a fifty-two week high of $21.60.

Avalon GloboCare Company Profile

Avalon GloboCare Corp., together with its subsidiaries, owns and operates commercial real estate properties in the United States and China. The company develops and delivers transformative cellular therapeutics, precision diagnostics, and clinical laboratory services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells.